Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helma Freitag

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pharmazie in Unserer Zeit|August 28, 2009
[Please a BiTE!]Helma Freitag, Gesine Gress, Kim Messer, et al.
Current Allergy and Asthma Reports|October 7, 2017
Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)Jan F Mieves, Kirsten Wittke, Helma Freitag, et al.
Neuroendocrinology|August 12, 2016
Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor DiseaseHelma Freitag, Friederike Christen, Florentine Lewens, et al.
Journal of Clinical Medicine|October 14, 2023
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim ReportElisa Stein, Cornelia Heindrich, Kirsten Wittke, et al.
Journal of Translational Medicine|April 20, 2021
Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFSBianka Jäkel, Claudia Kedor, Patricia Grabowski, et al.
Journal of Clinical Medicine|June 2, 2021
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept StudyCarmen Scheibenbogen, Franziska Sotzny, Jelka Hartwig, et al.
Journal of Clinical Medicine|February 26, 2025
Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFSAnnick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine|August 6, 2020
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat ImmunoadsorptionMarkus Tölle, Helma Freitag, Michaela Antelmann, et al.
Journal of Clinical Medicine|August 27, 2021
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeHelma Freitag, Marvin Szklarski, Sebastian Lorenz, et al.
The Lancet Regional Health. Europe|January 6, 2025
Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis/chronic fatigue syndrome and elevated β2-adrenergic receptor autoantibodies: a prospective cohort studyElisa Stein, Cornelia Heindrich, Kirsten Wittke, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pharmazie in Unserer Zeit|August 28, 2009
[Please a BiTE!]Helma Freitag, Gesine Gress, Kim Messer, et al.
Current Allergy and Asthma Reports|October 7, 2017
Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)Jan F Mieves, Kirsten Wittke, Helma Freitag, et al.
Neuroendocrinology|August 12, 2016
Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor DiseaseHelma Freitag, Friederike Christen, Florentine Lewens, et al.
Journal of Clinical Medicine|October 14, 2023
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim ReportElisa Stein, Cornelia Heindrich, Kirsten Wittke, et al.
Journal of Translational Medicine|April 20, 2021
Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFSBianka Jäkel, Claudia Kedor, Patricia Grabowski, et al.
Journal of Clinical Medicine|June 2, 2021
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept StudyCarmen Scheibenbogen, Franziska Sotzny, Jelka Hartwig, et al.
Journal of Clinical Medicine|February 26, 2025
Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFSAnnick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine|August 6, 2020
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat ImmunoadsorptionMarkus Tölle, Helma Freitag, Michaela Antelmann, et al.
Journal of Clinical Medicine|August 27, 2021
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeHelma Freitag, Marvin Szklarski, Sebastian Lorenz, et al.
The Lancet Regional Health. Europe|January 6, 2025
Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis/chronic fatigue syndrome and elevated β2-adrenergic receptor autoantibodies: a prospective cohort studyElisa Stein, Cornelia Heindrich, Kirsten Wittke, et al.
Pageof 3